Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

LH

Labcorp (LH)

Labcorp Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:LH
FechaHoraFuenteTítuloSímboloCompañía
17/12/202406:00PR Newswire (US)Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through PhysiciansNYSE:LHLabcorp Holdings Inc
04/12/202409:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
03/12/202408:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
02/12/202415:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
26/11/202407:05PR Newswire (US)Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer PatientsNYSE:LHLabcorp Holdings Inc
19/11/202406:13Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
19/11/202406:00PR Newswire (US)Labcorp CFO Glenn Eisenberg Announces Plans to RetireNYSE:LHLabcorp Holdings Inc
04/11/202408:00Business WirePraia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering ExperienceNYSE:LHLabcorp Holdings Inc
29/10/202410:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:LHLabcorp Holdings Inc
24/10/202405:50PR Newswire (US)Labcorp Announces 2024 Third Quarter ResultsNYSE:LHLabcorp Holdings Inc
18/10/202413:51Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:LHLabcorp Holdings Inc
16/10/202407:00Business WireNOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.NYSE:LHLabcorp Holdings Inc
10/10/202407:30PR Newswire (US)Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis TestNYSE:LHLabcorp Holdings Inc
10/10/202405:50PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
24/09/202415:16PR Newswire (US)Labcorp to Announce Third Quarter Financial Results on October 24, 2024NYSE:LHLabcorp Holdings Inc
18/09/202406:00PR Newswire (US)Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum ExperienceNYSE:LHLabcorp Holdings Inc
18/09/202405:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
16/09/202417:35PR Newswire (US)LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034NYSE:LHLabcorp Holdings Inc
16/09/202416:30Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LHLabcorp Holdings Inc
16/09/202406:30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNYSE:LHLabcorp Holdings Inc
03/09/202415:09PR Newswire (US)Labcorp to Speak at the Baird 2024 Global Healthcare ConferenceNYSE:LHLabcorp Holdings Inc
05/08/202406:00PR Newswire (US)Labcorp Finalizes Acquisition of Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
02/08/202407:30PR Newswire (US)Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus DxNYSE:LHLabcorp Holdings Inc
01/08/202405:57PR Newswire (US)Labcorp Announces 2024 Second Quarter ResultsNYSE:LHLabcorp Holdings Inc
30/07/202406:00PR Newswire (US)Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing CapabilitiesNYSE:LHLabcorp Holdings Inc
01/07/202406:00PR Newswire (US)Labcorp to Announce Second Quarter Financial Results on August 1, 2024NYSE:LHLabcorp Holdings Inc
17/06/202407:00PR Newswire (US)Labcorp Launches Global Trial Connect to Accelerate Clinical TrialsNYSE:LHLabcorp Holdings Inc
03/06/202416:23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NYSE:LHLabcorp Holdings Inc
03/06/202406:00PR Newswire (US)Labcorp Announces New Strategic Service Offerings within Precision Oncology PortfolioNYSE:LHLabcorp Holdings Inc
30/05/202412:18Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH